Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Stenson

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Gastroenterology|January 1, 1995
Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response?W F Stenson
The Year in Immunology|January 1, 1985
Pathogenesis of inflammatory bowel diseaseW F Stenson
Gastroenterology|February 1, 1997
Cyclooxygenase 2 and wound healing in the stomachW F Stenson
Current Protocols in Immunology|April 25, 2008
Measurement of prostaglandins and other eicosanoidsW F Stenson
Gastroenterology|November 1, 1988
Platelet-activating factor and inflammatory bowel diseaseW F Stenson
Current Opinion in Gastroenterology|October 13, 2006
Mechanisms of tissue protection and repair in inflammatory bowel diseaseW F Stenson
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1990
Role of eicosanoids as mediators of inflammation in inflammatory bowel diseaseW F Stenson
Immunopharmacology|January 1, 1988
A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acidH Allgayer, W F Stenson
Gastroenterology|January 1, 1985
Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel diseaseP Sharon, W F Stenson
The Journal of Clinical Investigation|February 1, 1982
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophilsW F Stenson, E Lobos
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Gastroenterology|January 1, 1995
Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response?W F Stenson
The Year in Immunology|January 1, 1985
Pathogenesis of inflammatory bowel diseaseW F Stenson
Gastroenterology|February 1, 1997
Cyclooxygenase 2 and wound healing in the stomachW F Stenson
Current Protocols in Immunology|April 25, 2008
Measurement of prostaglandins and other eicosanoidsW F Stenson
Gastroenterology|November 1, 1988
Platelet-activating factor and inflammatory bowel diseaseW F Stenson
Current Opinion in Gastroenterology|October 13, 2006
Mechanisms of tissue protection and repair in inflammatory bowel diseaseW F Stenson
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1990
Role of eicosanoids as mediators of inflammation in inflammatory bowel diseaseW F Stenson
Immunopharmacology|January 1, 1988
A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acidH Allgayer, W F Stenson
Gastroenterology|January 1, 1985
Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel diseaseP Sharon, W F Stenson
The Journal of Clinical Investigation|February 1, 1982
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophilsW F Stenson, E Lobos
Pageof 9